Radiation-Induced Esophagitis Exacerbated by Everolimus

BACKGROUND: Everolimus, a potent mammalian target of rapamycin (mTOR) inhibitor, has shown anticancer activity against various types of cancer, including renal cell carcinoma (RCC); however, little information is available on the efficacy and safety of the combination of everolimus and radiotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Yuji, Suyama, Koichi, Shimomura, Akihiko, Miyakawa, Jimpei, Kobayashi, Hiroki, Uki, Akiyoshi, Okaneya, Toshikazu, Takano, Toshimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Published online: June, 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725027/
https://www.ncbi.nlm.nih.gov/pubmed/23898276
http://dx.doi.org/10.1159/000353309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725027/
https://www.ncbi.nlm.nih.gov/pubmed/23898276
http://dx.doi.org/10.1159/000353309

Ejemplares similares